カテゴリ： Infiniti Research TechNavio, 世界, 医療/バイオ

世界の女性性機能不全治療市場2023～2027：40歳以上、40代以下

■ 英語タイトル：Global Female Sexual Dysfunction Treatment Market 2023-2027

調査会社Technavio社が発行したリサーチレポート（データ管理コード：IRTNTR70409-23）■ 発行会社/調査会社：Technavio
■ 商品コード：IRTNTR70409-23
■ 発行日：2022年11月23日
■ 調査対象地域：グローバル
■ 産業分野：医療
■ ページ数：120
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（受注後24時間以内）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD2,500 ⇒換算￥380,000見積依頼/購入/質問フォーム
Enterprise License（同一法人内共有可）USD4,000 ⇒換算￥608,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※Technavio社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の女性性機能不全治療市場2023～2027：40歳以上、40代以下]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

Technavio社発行の当調査レポートは、世界の女性性機能不全治療市場規模が2022年から2027年まで年平均34.28%成長し、7760.77百万ドルに達すると予測しています。当レポートでは、女性性機能不全治療の世界市場について総合的に調査・分析を行い、エグゼクティブサマリー、市場状況、市場規模、過去の市場規模、ファイブフォース分析、年齢層別（40歳以上、40代以下）分析、製品別（非ホルモン療法、ホルモン療法）分析、顧客状況、地域別状況（北米、ヨーロッパ、アジア太平洋、アメリカ、カナダ、ドイツ、イギリス、フランス、その他地域）分析、推進要因・課題・動向、企業状況、企業分析などの内容をまとめております。なお、参入企業情報として、Assos Ilac、Cipla Ltd.、Dare Bioscience Inc.、Dr Reddys Laboratories Ltd.、Duchesnay Inc.、Endo International Plc、Freya Pharma Solutions B.V.、Lupin Ltd.、Mithra Pharmaceuticals SA、Novo Nordisk AS、Palatin Technologies Inc.、Pfizer Inc.、Pharmbio Korea Inc.、Sprout Pharmaceuticals Inc.、Strategic Science and Technologies LLCなどが含まれています。
・エグゼクティブサマリー
・市場状況
・市場規模
・過去の市場規模
・ファイブフォース分析

・世界の女性性機能不全治療市場規模：年齢層別
- 40歳以上の市場規模
- 40代以下の市場規模

・世界の女性性機能不全治療市場規模：製品別
- 非ホルモン療法の市場規模
- ホルモン療法の市場規模

・顧客状況

・地域別状況
- 北米の女性性機能不全治療市場規模
- ヨーロッパの女性性機能不全治療市場規模
- アジア太平洋の女性性機能不全治療市場規模
- アメリカの女性性機能不全治療市場規模
- カナダの女性性機能不全治療市場規模
- ドイツの女性性機能不全治療市場規模
- イギリスの女性性機能不全治療市場規模
- フランスの女性性機能不全治療市場規模
- その他地域の女性性機能不全治療市場規模

・推進要因・課題・動向
・企業状況
・企業分析

Technavio社は、利益、価格、競争、プロモーションなどの主要なパラメーターの分析によって得られた複数のソースからのデータを、調査・統合・総括することにより、市場の全体像を詳しく提示します。主要な業界のインフルエンサーを特定することにより、多様な市場の側面を提供します。これらのデータは包括的​​で信頼性が高く、一次・二次の広範な研究の結果です。Technavio社の市場調査書は、確かな市場の成長を予測するための定性的、定量的調査を行い、完全な競争状況、そして詳細なベンダー選択方法と分析を提供します。

女性性機能不全治療の世界市場 2023-2027

Technavio社は、女性性機能不全治療市場をモニターしており、2023年から2027年にかけて7,760.77百万ドルの成長が見込まれ、予測期間中のCAGRは34.28%で加速すると予測しています。当レポートでは、女性性機能不全治療市場について、市場規模や予測、動向、成長促進要因、課題、さらに約25のベンダーを網羅したベンダー分析など、包括的な分析を提供しています。

当レポートでは、現在の世界市場のシナリオ、最新動向と促進要因、市場全体の環境に関する最新分析を提供しています。市場は、慢性疾患の有病率の増加、女性の性機能障害に対する意識の高まり、低活動性性欲障害の治療薬の承認と入手可能性によって牽引されています。

Technavioの女性性機能障害治療市場は以下のように区分されます：

・年齢層別：
– 40歳以上
– 40歳以下

・製品別：
– 非ホルモン療法
– ホルモン療法

・地域別：
– 北米
– ヨーロッパ
– アジア
– その他の地域（ROW）

本調査では、今後数年間における女性性機能不全治療市場の成長を促進する主な理由の一つとして、女性性機能不全治療のための研究開発の増加を挙げています。また、女性性機能不全治療に関する安全ラベルの変更や、女性の性機能障害の原因となる薬剤の使用の増加は、市場の大きな需要につながるでしょう。

Technavio社は、複数の情報源からのデータを調査、統合、要約し、主要パラメータの分析によって、市場の詳細な姿を提示します。

当レポートでは、女性性機能不全治療市場について以下の分野をカバーしています：
– 女性性機能不全治療市場規模
– 女性性機能障害治療市場予測
– 女性性機能不全治療市場産業分析

Technavio社の確実なベンダー分析は、クライアントが市場でのポジションを向上できるように設計されており、これに沿って本レポートには、Assos Ilac, Cipla Ltd., Dare Bioscience Inc., Dr Reddys Laboratories Ltd., Duchesnay Inc., Endo International Plc, Freya Pharma Solutions B.V., Lupin Ltd., Mithra Pharmaceuticals SA, Novo Nordisk AS, Palatin Technologies Inc., Pfizer Inc., Pharmbio Korea Inc., Sprout Pharmaceuticals Inc., Strategic Science and Technologies LLC, Teva Pharmaceutical Industries Ltd., and Viatris Incなどの企業情報が含まれています。また、女性性機能障害治療市場分析レポートには、市場成長に影響を与える今後の動向や課題に関する情報も含まれています。これは、企業が戦略を立て、来るべき成長機会をすべて活用するのに役立つものです。

本調査は、業界の主要参加者からのインプットを含め、一次情報と二次情報を客観的に組み合わせて実施しました。本レポートでは、主要ベンダーの分析に加え、包括的な市場およびベンダーの状況を掲載しています。

Technavioは、利益、価格、競争、プロモーションなどの主要パラメータの分析により、複数の情報源からのデータを調査、統合、要約する方法で、市場の詳細な姿を提示します。また、主要な業界インフルエンサーを特定することで、市場の様々な側面を提示します。提示されるデータは包括的で信頼性が高く、一次および二次にわたる広範な調査の結果です。Technavioの市場調査レポートは、正確な市場成長を予測するために、完全な競争環境と、質的・量的調査を用いた綿密なベンダー選定方法と分析を提供します。

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

• 1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Age Group
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
• 2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
• 3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
• 4 Historic Market Size
o 4.1 Global female sexual dysfunction treatment market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on Global female sexual dysfunction treatment market 2017 – 2021 ($ million)
o 4.2 Age Group Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Age Group Segment 2017 – 2021 ($ million)
o 4.3 Product Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Product Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
• 5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
• 6 Market Segmentation by Age Group
o 6.1 Market segments
o Exhibit 30: Chart on Age Group – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Age Group – Market share 2022-2027 (%)
o 6.2 Comparison by Age Group
o Exhibit 32: Chart on Comparison by Age Group
o Exhibit 33: Data Table on Comparison by Age Group
o 6.3 Above 40 years – Market size and forecast 2022-2027
o Exhibit 34: Chart on Above 40 years – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Above 40 years – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Above 40 years – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Above 40 years – Year-over-year growth 2022-2027 (%)
o 6.4 Below 40 years – Market size and forecast 2022-2027
o Exhibit 38: Chart on Below 40 years – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Below 40 years – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Below 40 years – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Below 40 years – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Age Group
o Exhibit 42: Market opportunity by Age Group ($ million)
• 7 Market Segmentation by Product
o 7.1 Market segments
o Exhibit 43: Chart on Product – Market share 2022-2027 (%)
o Exhibit 44: Data Table on Product – Market share 2022-2027 (%)
o 7.2 Comparison by Product
o Exhibit 45: Chart on Comparison by Product
o Exhibit 46: Data Table on Comparison by Product
o 7.3 Non-hormonal therapy – Market size and forecast 2022-2027
o Exhibit 47: Chart on Non-hormonal therapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 48: Data Table on Non-hormonal therapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Chart on Non-hormonal therapy – Year-over-year growth 2022-2027 (%)
o Exhibit 50: Data Table on Non-hormonal therapy – Year-over-year growth 2022-2027 (%)
o 7.4 Hormonal therapy – Market size and forecast 2022-2027
o Exhibit 51: Chart on Hormonal therapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 52: Data Table on Hormonal therapy – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Chart on Hormonal therapy – Year-over-year growth 2022-2027 (%)
o Exhibit 54: Data Table on Hormonal therapy – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Product
o Exhibit 55: Market opportunity by Product ($ million)
• 8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
• 9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 57: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 59: Chart on Geographic comparison
o Exhibit 60: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 61: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 62: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 63: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 64: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 65: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 66: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 67: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 68: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 69: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 70: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 71: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 72: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 73: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 74: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 75: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 76: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 77: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 78: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 79: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 80: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Canada – Market size and forecast 2022-2027
o Exhibit 81: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 82: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 83: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 84: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.9 Germany – Market size and forecast 2022-2027
o Exhibit 85: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 86: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 87: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.10 UK – Market size and forecast 2022-2027
o Exhibit 89: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 90: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 91: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 92: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.11 France – Market size and forecast 2022-2027
o Exhibit 93: Chart on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 94: Data Table on France – Market size and forecast 2022-2027 ($ million)
o Exhibit 95: Chart on France – Year-over-year growth 2022-2027 (%)
o Exhibit 96: Data Table on France – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 97: Market opportunity By Geographical Landscape ($ million)
• 10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 98: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
• 11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 99: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 100: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 101: Impact of key risks on business
• 12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 102: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 103: Matrix on vendor position and classification
o 12.3 Cipla Ltd.
o Exhibit 104: Cipla Ltd. – Overview
o Exhibit 105: Cipla Ltd. – Business segments
o Exhibit 106: Cipla Ltd. – Key news
o Exhibit 107: Cipla Ltd. – Key offerings
o Exhibit 108: Cipla Ltd. – Segment focus
o 12.4 Dare Bioscience Inc.
o Exhibit 109: Dare Bioscience Inc. – Overview
o Exhibit 110: Dare Bioscience Inc. – Product / Service
o Exhibit 111: Dare Bioscience Inc. – Key offerings
o 12.5 Dr Reddys Laboratories Ltd.
o Exhibit 112: Dr Reddys Laboratories Ltd. – Overview
o Exhibit 113: Dr Reddys Laboratories Ltd. – Business segments
o Exhibit 114: Dr Reddys Laboratories Ltd. – Key offerings
o Exhibit 115: Dr Reddys Laboratories Ltd. – Segment focus
o 12.6 Duchesnay Inc.
o Exhibit 116: Duchesnay Inc. – Overview
o Exhibit 117: Duchesnay Inc. – Product / Service
o Exhibit 118: Duchesnay Inc. – Key offerings
o 12.7 Endo International Plc
o Exhibit 119: Endo International Plc – Overview
o Exhibit 120: Endo International Plc – Business segments
o Exhibit 121: Endo International Plc – Key news
o Exhibit 122: Endo International Plc – Key offerings
o Exhibit 123: Endo International Plc – Segment focus
o 12.8 Freya Pharma Solutions B.V.
o Exhibit 124: Freya Pharma Solutions B.V. – Overview
o Exhibit 125: Freya Pharma Solutions B.V. – Product / Service
o Exhibit 126: Freya Pharma Solutions B.V. – Key offerings
o 12.9 Lupin Ltd.
o Exhibit 127: Lupin Ltd. – Overview
o Exhibit 128: Lupin Ltd. – Product / Service
o Exhibit 129: Lupin Ltd. – Key news
o Exhibit 130: Lupin Ltd. – Key offerings
o 12.10 Mithra Pharmaceuticals SA
o Exhibit 131: Mithra Pharmaceuticals SA – Overview
o Exhibit 132: Mithra Pharmaceuticals SA – Product / Service
o Exhibit 133: Mithra Pharmaceuticals SA – Key offerings
o 12.11 Novo Nordisk AS
o Exhibit 134: Novo Nordisk AS – Overview
o Exhibit 135: Novo Nordisk AS – Business segments
o Exhibit 136: Novo Nordisk AS – Key offerings
o Exhibit 137: Novo Nordisk AS – Segment focus
o 12.12 Palatin Technologies Inc.
o Exhibit 138: Palatin Technologies Inc. – Overview
o Exhibit 139: Palatin Technologies Inc. – Product / Service
o Exhibit 140: Palatin Technologies Inc. – Key offerings
o 12.13 Pfizer Inc.
o Exhibit 141: Pfizer Inc. – Overview
o Exhibit 142: Pfizer Inc. – Product / Service
o Exhibit 143: Pfizer Inc. – Key news
o Exhibit 144: Pfizer Inc. – Key offerings
o 12.14 Sprout Pharmaceuticals Inc.
o Exhibit 145: Sprout Pharmaceuticals Inc. – Overview
o Exhibit 146: Sprout Pharmaceuticals Inc. – Product / Service
o Exhibit 147: Sprout Pharmaceuticals Inc. – Key offerings
o 12.15 Strategic Science and Technologies LLC
o Exhibit 148: Strategic Science and Technologies LLC – Overview
o Exhibit 149: Strategic Science and Technologies LLC – Product / Service
o Exhibit 150: Strategic Science and Technologies LLC – Key offerings
o 12.16 Teva Pharmaceutical Industries Ltd.
o Exhibit 151: Teva Pharmaceutical Industries Ltd. – Overview
o Exhibit 152: Teva Pharmaceutical Industries Ltd. – Business segments
o Exhibit 153: Teva Pharmaceutical Industries Ltd. – Key news
o Exhibit 154: Teva Pharmaceutical Industries Ltd. – Key offerings
o Exhibit 155: Teva Pharmaceutical Industries Ltd. – Segment focus
o 12.17 Viatris Inc.
o Exhibit 156: Viatris Inc. – Overview
o Exhibit 157: Viatris Inc. – Business segments
o Exhibit 158: Viatris Inc. – Key offerings
o Exhibit 159: Viatris Inc. – Segment focus
• 13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 160: Inclusions checklist
o Exhibit 161: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 162: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 163: Research methodology
o Exhibit 164: Validation techniques employed for market sizing
o Exhibit 165: Information sources
o 13.5 List of abbreviations
o Exhibit 166: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Age Group
Exhibits6: Executive Summary – Chart on Market Segmentation by Product
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on Global female sexual dysfunction treatment market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Age Group Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Product Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Age Group – Market share 2022-2027 (%)
Exhibits31: Data Table on Age Group – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Age Group
Exhibits33: Data Table on Comparison by Age Group
Exhibits34: Chart on Above 40 years – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Above 40 years – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Above 40 years – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Above 40 years – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Below 40 years – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Below 40 years – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Below 40 years – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Below 40 years – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Age Group ($ million)
Exhibits43: Chart on Product – Market share 2022-2027 (%)
Exhibits44: Data Table on Product – Market share 2022-2027 (%)
Exhibits45: Chart on Comparison by Product
Exhibits46: Data Table on Comparison by Product
Exhibits47: Chart on Non-hormonal therapy – Market size and forecast 2022-2027 ($ million)
Exhibits48: Data Table on Non-hormonal therapy – Market size and forecast 2022-2027 ($ million)
Exhibits49: Chart on Non-hormonal therapy – Year-over-year growth 2022-2027 (%)
Exhibits50: Data Table on Non-hormonal therapy – Year-over-year growth 2022-2027 (%)
Exhibits51: Chart on Hormonal therapy – Market size and forecast 2022-2027 ($ million)
Exhibits52: Data Table on Hormonal therapy – Market size and forecast 2022-2027 ($ million)
Exhibits53: Chart on Hormonal therapy – Year-over-year growth 2022-2027 (%)
Exhibits54: Data Table on Hormonal therapy – Year-over-year growth 2022-2027 (%)
Exhibits55: Market opportunity by Product ($ million)
Exhibits56: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits57: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits58: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits59: Chart on Geographic comparison
Exhibits60: Data Table on Geographic comparison
Exhibits61: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits62: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits63: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits64: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits65: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits66: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits67: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits68: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits69: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits70: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits71: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits72: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits73: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits74: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits75: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits76: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits77: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits78: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits79: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits80: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits81: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits82: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits83: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits84: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits85: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits86: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits87: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits88: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits89: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits90: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits91: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits92: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits93: Chart on France – Market size and forecast 2022-2027 ($ million)
Exhibits94: Data Table on France – Market size and forecast 2022-2027 ($ million)
Exhibits95: Chart on France – Year-over-year growth 2022-2027 (%)
Exhibits96: Data Table on France – Year-over-year growth 2022-2027 (%)
Exhibits97: Market opportunity By Geographical Landscape ($ million)
Exhibits98: Impact of drivers and challenges in 2022 and 2027
Exhibits99: Overview on Criticality of inputs and Factors of differentiation
Exhibits100: Overview on factors of disruption
Exhibits101: Impact of key risks on business
Exhibits102: Vendors covered
Exhibits103: Matrix on vendor position and classification
Exhibits104: Cipla Ltd. – Overview
Exhibits105: Cipla Ltd. – Business segments
Exhibits106: Cipla Ltd. – Key news
Exhibits107: Cipla Ltd. – Key offerings
Exhibits108: Cipla Ltd. – Segment focus
Exhibits109: Dare Bioscience Inc. – Overview
Exhibits110: Dare Bioscience Inc. – Product / Service
Exhibits111: Dare Bioscience Inc. – Key offerings
Exhibits112: Dr Reddys Laboratories Ltd. – Overview
Exhibits113: Dr Reddys Laboratories Ltd. – Business segments
Exhibits114: Dr Reddys Laboratories Ltd. – Key offerings
Exhibits115: Dr Reddys Laboratories Ltd. – Segment focus
Exhibits116: Duchesnay Inc. – Overview
Exhibits117: Duchesnay Inc. – Product / Service
Exhibits118: Duchesnay Inc. – Key offerings
Exhibits119: Endo International Plc – Overview
Exhibits120: Endo International Plc – Business segments
Exhibits121: Endo International Plc – Key news
Exhibits122: Endo International Plc – Key offerings
Exhibits123: Endo International Plc – Segment focus
Exhibits124: Freya Pharma Solutions B.V. – Overview
Exhibits125: Freya Pharma Solutions B.V. – Product / Service
Exhibits126: Freya Pharma Solutions B.V. – Key offerings
Exhibits127: Lupin Ltd. – Overview
Exhibits128: Lupin Ltd. – Product / Service
Exhibits129: Lupin Ltd. – Key news
Exhibits130: Lupin Ltd. – Key offerings
Exhibits131: Mithra Pharmaceuticals SA – Overview
Exhibits132: Mithra Pharmaceuticals SA – Product / Service
Exhibits133: Mithra Pharmaceuticals SA – Key offerings
Exhibits134: Novo Nordisk AS – Overview
Exhibits135: Novo Nordisk AS – Business segments
Exhibits136: Novo Nordisk AS – Key offerings
Exhibits137: Novo Nordisk AS – Segment focus
Exhibits138: Palatin Technologies Inc. – Overview
Exhibits139: Palatin Technologies Inc. – Product / Service
Exhibits140: Palatin Technologies Inc. – Key offerings
Exhibits141: Pfizer Inc. – Overview
Exhibits142: Pfizer Inc. – Product / Service
Exhibits143: Pfizer Inc. – Key news
Exhibits144: Pfizer Inc. – Key offerings
Exhibits145: Sprout Pharmaceuticals Inc. – Overview
Exhibits146: Sprout Pharmaceuticals Inc. – Product / Service
Exhibits147: Sprout Pharmaceuticals Inc. – Key offerings
Exhibits148: Strategic Science and Technologies LLC – Overview
Exhibits149: Strategic Science and Technologies LLC – Product / Service
Exhibits150: Strategic Science and Technologies LLC – Key offerings
Exhibits151: Teva Pharmaceutical Industries Ltd. – Overview
Exhibits152: Teva Pharmaceutical Industries Ltd. – Business segments
Exhibits153: Teva Pharmaceutical Industries Ltd. – Key news
Exhibits154: Teva Pharmaceutical Industries Ltd. – Key offerings
Exhibits155: Teva Pharmaceutical Industries Ltd. – Segment focus
Exhibits156: Viatris Inc. – Overview
Exhibits157: Viatris Inc. – Business segments
Exhibits158: Viatris Inc. – Key offerings
Exhibits159: Viatris Inc. – Segment focus
Exhibits160: Inclusions checklist
Exhibits161: Exclusions checklist
Exhibits162: Currency conversion rates for US$
Exhibits163: Research methodology
Exhibits164: Validation techniques employed for market sizing
Exhibits165: Information sources
Exhibits166: List of abbreviations



*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 女性化乳房手術のグローバル市場2023-2030：18～40歳、40歳以上
  • 電子顕微鏡のグローバル市場2023-2027：半導体、ライフサイエンス、材料科学、ナノテクノロジー
  • 半導体パッケージング材料のグローバル市場2023-2027：有機基板、リードフレーム、ボンディングワイヤ、セラミックパッケージ、その他
  • 携帯式浄水器の世界市場2023～2027
  • 自律型水中探査機（AUV）のグローバル市場2023-2027：通信、衝突回避、ナビゲーション、推進、イメージング
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(IRTNTR70409-23 )"世界の女性性機能不全治療市場2023～2027：40歳以上、40代以下" (英文：Global Female Sexual Dysfunction Treatment Market 2023-2027)はTechnavio社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。